Update in atherothrombotic disease

Juan F Viles-Gonzalez1, Sunil X Anand, Carolina Valdiviezo

  • 1Cardiovascular Biology Research Laboratory, Zena and Michael A. Wiener Cardiovascular Institute, Box 1030, Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029, USA.

Insights

Advances in understanding atherothrombosis reveal complex pathogenesis beyond lipid accumulation. Key factors include endothelial dysfunction, inflammation, apoptosis, and tissue factor, influencing plaque thrombogenicity and acute coronary syndromes.

Area of Science:

  • Cardiovascular Medicine
  • Pathogenesis of Atherothrombosis
  • Thrombotic Complications

Background:

  • The understanding of atherothrombosis, encompassing atherosclerosis and its thrombotic complications, has significantly evolved over the last two decades.
  • The traditional "lipid accumulation" hypothesis has been expanded to incorporate multiple factors in disease initiation and progression.
  • Endothelial dysfunction is recognized as the earliest event in atherogenesis, with inflammation and apoptosis playing critical roles.

Purpose of the Study:

  • To review emerging concepts in the pathogenesis of atherothrombotic disease.
  • To discuss novel therapeutic approaches for managing atherothrombotic conditions.
  • To integrate current understanding of molecular and cellular mechanisms driving atherothrombosis.

Main Methods:

  • Review of recent scientific literature on atherothrombosis.
  • Synthesis of data on endothelial dysfunction, inflammation, apoptosis, and tissue factor.
  • Analysis of the role of "vulnerable blood" in acute coronary syndromes.

Main Results:

  • Atherothrombosis pathogenesis is multifactorial, involving more than just lipid accumulation.
  • Endothelial dysfunction, inflammation, apoptosis, and tissue factor are key contributors to plaque development and thrombogenicity.
  • A hyperreactive blood state may account for a significant portion of acute coronary syndromes.

Conclusions:

  • Current understanding of atherothrombosis integrates multiple pathogenic pathways.
  • Targeting these pathways offers potential for new therapeutic strategies.
  • Further research is needed to fully elucidate and exploit these emerging concepts for clinical benefit.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...